GRANULES INDIA
Back to Income Statement
|
GRANULES INDIA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹502 Cr | ₹405 Cr | ₹517 Cr | ₹413 Cr | ₹5,495 Cr |
What is the latest Consolidated Net Profit of GRANULES INDIA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹502 Cr |
| Mar2025 | ₹405 Cr |
| Mar2024 | ₹517 Cr |
| Mar2023 | ₹413 Cr |
| Mar2022 | ₹5,495 Cr |
How is Consolidated Net Profit of GRANULES INDIA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹502 Cr | 23.74 | |
| Mar2025 | ₹405 Cr | -21.54 | |
| Mar2024 | ₹517 Cr | 25.16 | |
| Mar2023 | ₹413 Cr | -92.49 | |
| Mar2022 | ₹5,495 Cr | - | |
Compare Consolidated Net Profit of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹22,238.7 Cr | -0.7% | -5.9% | 56% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -0.7% |
-5.9% |
56% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses